Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Pooled RCTs: Adding LABAs to ICSs do not increase serious asthma events and reduce exacerbations.

Peters JI, Maselli DJ.

Ann Intern Med. 2018 Nov 20;169(10):JC53. doi: 10.7326/ACPJC-2018-169-10-053. No abstract available.

PMID:
30452560
2.

Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use.

Maselli DJ, Rogers L, Peters JI.

Ther Clin Risk Manag. 2018 Oct 23;14:2059-2068. doi: 10.2147/TCRM.S157171. eCollection 2018. Review.

3.

Clinical Approach to the Therapy of Asthma-COPD Overlap.

Maselli DJ, Hardin M, Christenson SA, Hanania NA, Hersh CP, Adams SG, Anzueto A, Peters JI, Han MK, Martinez FJ.

Chest. 2019 Jan;155(1):168-177. doi: 10.1016/j.chest.2018.07.028. Epub 2018 Aug 2. Review.

PMID:
30077690
4.

Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbations.

Maselli DJ, Peters JI.

Ann Intern Med. 2018 Jun 19;168(12):JC65. doi: 10.7326/ACPJC-2018-168-12-065. No abstract available.

PMID:
29913490
5.

Medication Regimens for Managing Acute Asthma.

Maselli DJ, Peters JI.

Respir Care. 2018 Jun;63(6):783-796. doi: 10.4187/respcare.05953. Review.

6.

In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 months.

Maselli DJ, Peters JI.

Ann Intern Med. 2017 Oct 17;167(8):JC43. doi: 10.7326/ACPJC-2017-167-8-043. No abstract available.

PMID:
29049762
7.

The efficacy of inhaled nanoparticle tacrolimus in preventing rejection in an orthotopic rat lung transplant model.

Das NA, Peters JI, Simmons JD, Wang Y, O'Donnell KP, DeArmond DT, Coalson JJ, Brooks EG, Johnson SB.

J Thorac Cardiovasc Surg. 2017 Dec;154(6):2144-2151.e1. doi: 10.1016/j.jtcvs.2017.07.083. Epub 2017 Sep 1.

PMID:
28942970
8.

The Immunopathologic Effects of Mycoplasma pneumoniae and Community-acquired Respiratory Distress Syndrome Toxin. A Primate Model.

Maselli DJ, Medina JL, Brooks EG, Coalson JJ, Kannan TR, Winter VT, Principe M, Cagle MP, Baseman JB, Dube PH, Peters JI.

Am J Respir Cell Mol Biol. 2018 Feb;58(2):253-260. doi: 10.1165/rcmb.2017-0006OC.

9.

High endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis.

Mangat M, Amalakuhan B, Habib S, Reyes LF, Hinojosa CA, Rodriguez AH, Soni NJ, Anzueto A, Levine SM, Peters JI, Aliberti S, Sibila O, Rello J, Witzenrath M, Waterer GW, Martin-Loeches I, Blanquer J, Sanz F, Marcos PJ, Solé-Violán J, Chalmers JD, Feldman C, Wunderink RG, Cruz CSD, Orihuela CJ, Restrepo MI.

Eur Respir J. 2017 Jul 5;50(1). pii: 1700013. doi: 10.1183/13993003.00013-2017. Print 2017 Jul. No abstract available.

10.

Mycoplasma pneumoniae and health outcomes in children with asthma.

Wood PR, Kampschmidt JC, Dube PH, Cagle MP, Chaparro P, Ketchum NS, Kannan TR, Singh H, Peters JI, Baseman JB, Brooks EG.

Ann Allergy Asthma Immunol. 2017 Aug;119(2):146-152.e2. doi: 10.1016/j.anai.2017.05.022. Epub 2017 Jun 19.

11.

Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis.

Nambiar AM, Anzueto AR, Peters JI.

PLoS One. 2017 Apr 25;12(4):e0176312. doi: 10.1371/journal.pone.0176312. eCollection 2017.

12.

In refractory chronic cough, physiotherapy plus speech and language therapy improved quality of life at 4 weeks.

Maselli DJ, Peters JI.

Ann Intern Med. 2017 Jan 17;166(2):JC3. doi: 10.7326/ACPJC-2017-166-2-003. No abstract available.

PMID:
28114459
13.

Use of ultrasound guidance for central venous catheterization: a national survey of intensivists and hospitalists.

Soni NJ, Reyes LF, Keyt H, Arango A, Gelfond JA, Peters JI, Levine SM, Adams SG, Restrepo MI.

J Crit Care. 2016 Dec;36:277-283. doi: 10.1016/j.jcrc.2016.07.014. Epub 2016 Jul 17.

PMID:
27491563
14.

Endothelial adhesion molecules and multiple organ failure in patients with severe sepsis.

Amalakuhan B, Habib SA, Mangat M, Reyes LF, Rodriguez AH, Hinojosa CA, Soni NJ, Gilley RP, Bustamante CA, Anzueto A, Levine SM, Peters JI, Aliberti S, Sibila O, Chalmers JD, Torres A, Waterer GW, Martin-Loeches I, Bordon J, Blanquer J, Sanz F, Marcos PJ, Rello J, Ramirez J, Solé-Violán J, Luna CM, Feldman C, Witzenrath M, Wunderink RG, Stolz D, Wiemken TL, Shindo Y, Dela Cruz CS, Orihuela CJ, Restrepo MI.

Cytokine. 2016 Dec;88:267-273. doi: 10.1016/j.cyto.2016.08.028. Epub 2016 Oct 1.

15.

Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection.

Maincent JP, Najvar LK, Kirkpatrick WR, Huang S, Patterson TF, Wiederhold NP, Peters JI, Williams RO 3rd.

Drug Dev Ind Pharm. 2017 Feb;43(2):264-274. doi: 10.1080/03639045.2016.1236811. Epub 2016 Oct 5.

16.

Diagnosis and Management of Sarcoidosis.

Soto-Gomez N, Peters JI, Nambiar AM.

Am Fam Physician. 2016 May 15;93(10):840-8.

17.

ACP Journal Club. Review: In COPD, tiotropium improves lung function and reduces adverse events compared with ipratropium bromide.

Maselli DJ, Peters JI.

Ann Intern Med. 2016 Jan 19;164(2):JC6. doi: 10.7326/ACPJC-2016-164-2-006. No abstract available.

PMID:
26784496
18.

Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery.

Liu S, Watts AB, Du J, Bui A, Hengsawas S, Peters JI, Williams RO 3rd.

Eur J Pharm Biopharm. 2015 Oct;96:132-42. doi: 10.1016/j.ejpb.2015.07.017. Epub 2015 Jul 26.

PMID:
26220015
19.

Iatrogenic Endobronchial Bleeding: Speed Things Up or Cool It Down?

Oh S, Peters JI, Folch E.

J Bronchology Interv Pulmonol. 2015 Jul;22(3):191-4. doi: 10.1097/LBR.0000000000000197. No abstract available.

PMID:
26165888
20.

ACP Journal Club. Review: Adding tiotropium to ICSs alone or with LABAs improves pulmonary function in asthma.

Maselli DJ, Peters JI.

Ann Intern Med. 2015 Jun 16;162(12):JC5. doi: 10.7326/ACPJC-2015-162-12-005. No abstract available.

PMID:
26075782
21.

An official American Thoracic Society/American College of Chest Physicians policy statement: the Choosing Wisely top five list in adult pulmonary medicine.

Wiener RS, Ouellette DR, Diamond E, Fan VS, Maurer JR, Mularski RA, Peters JI, Halpern SD.

Chest. 2014 Jun;145(6):1383-1391. doi: 10.1378/chest.14-0670.

22.

Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats.

Carvalho SR, Watts AB, Peters JI, Liu S, Hengsawas S, Escotet-Espinoza MS, Williams RO 3rd.

Eur J Pharm Biopharm. 2014 Sep;88(1):136-47. doi: 10.1016/j.ejpb.2014.05.008. Epub 2014 May 22.

PMID:
24859653
23.

In vitro and in vivo performance of dry powder inhalation formulations: comparison of particles prepared by thin film freezing and micronization.

Wang YB, Watts AB, Peters JI, Liu S, Batra A, Williams RO 3rd.

AAPS PharmSciTech. 2014 Aug;15(4):981-93. doi: 10.1208/s12249-014-0126-7. Epub 2014 May 14.

24.

The impact of pulmonary diseases on the fate of inhaled medicines--a review.

Wang YB, Watts AB, Peters JI, Williams RO 3rd.

Int J Pharm. 2014 Jan 30;461(1-2):112-28. doi: 10.1016/j.ijpharm.2013.11.042. Epub 2013 Nov 27. Review.

PMID:
24291124
25.

5 days of prednisone was noninferior to 14 days in patients with acute COPD exacerbation.

Maselli DJ, Peters JI.

Ann Intern Med. 2013 Sep 17;159(6):JC5. doi: 10.7326/0003-4819-159-6-201309170-02005. No abstract available.

PMID:
24042388
26.

Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model.

Bayer J, Das NA, Baisden CE, Rani M, DeArmond DT, Peters JI, Johnson SB.

J Thorac Cardiovasc Surg. 2013 Nov;146(5):1213-9; discussion 1219. doi: 10.1016/j.jtcvs.2013.07.030. Epub 2013 Sep 9.

27.

Assessing proxy reports: agreement between children with asthma and their caregivers on quality of life.

Burks ML, Brooks EG, Hill VL, Peters JI, Wood PR.

Ann Allergy Asthma Immunol. 2013 Jul;111(1):14-9. doi: 10.1016/j.anai.2013.05.008. Erratum in: Ann Allergy Asthma Immunol. 2013 Oct;111(4):309.

28.

Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU/mL: a retrospective study.

Maselli DJ, Singh H, Diaz J, Peters JI.

Ann Allergy Asthma Immunol. 2013 Jun;110(6):457-61. doi: 10.1016/j.anai.2013.04.011.

PMID:
23706716
29.

Mycoplasma pneumoniae in children with acute and refractory asthma.

Wood PR, Hill VL, Burks ML, Peters JI, Singh H, Kannan TR, Vale S, Cagle MP, Principe MF, Baseman JB, Brooks EG.

Ann Allergy Asthma Immunol. 2013 May;110(5):328-334.e1. doi: 10.1016/j.anai.2013.01.022. Epub 2013 Feb 23. Erratum in: Ann Allergy Asthma Immunol. 2013 Oct;111(4):309.

30.

ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD.

Adams SG, Peters JI.

Ann Intern Med. 2013 Mar 19;158(6):JC3. doi: 10.7326/0003-4819-158-6-201303190-02003. No abstract available.

PMID:
23552686
31.

Nebulization of mycophenolate mofetil inhalation suspension in rats: comparison with oral and pulmonary administration of Cellcept®.

Dugas HL, Peters JI, Williams RO 3rd.

Int J Pharm. 2013 Jan 30;441(1-2):19-29. doi: 10.1016/j.ijpharm.2012.12.016. Epub 2012 Dec 20.

PMID:
23262419
32.

Management of asthma during pregnancy.

Maselli DJ, Adams SG, Peters JI, Levine SM.

Ther Adv Respir Dis. 2013 Apr;7(2):87-100. doi: 10.1177/1753465812464287. Epub 2012 Nov 5. Review.

PMID:
23129568
33.

Cystic lung lesions in Sjogren syndrome: analysis of lymphocyte subsets in tissue with clinico-radiologic-pathologic correlation.

Jagirdar J, Chikkamuniyappa S, Sirohi D, McCarthy MJ, Peters JI.

Ann Diagn Pathol. 2013 Feb;17(1):113-6. doi: 10.1016/j.anndiagpath.2012.03.005. Epub 2012 Jun 1.

PMID:
22658853
34.

Lung transplantation for Williams-Campbell syndrome with a probable familial association.

Burguete SR, Levine SM, Restrepo MI, Angel LF, Levine DJ, Coalson JJ, Peters JI.

Respir Care. 2012 Sep;57(9):1505-8. doi: 10.4187/respcare.01484. Epub 2012 Feb 17.

35.

Status asthmaticus in the medical intensive care unit: a 30-year experience.

Peters JI, Stupka JE, Singh H, Rossrucker J, Angel LF, Melo J, Levine SM.

Respir Med. 2012 Mar;106(3):344-8. doi: 10.1016/j.rmed.2011.11.015. Epub 2011 Dec 20.

36.

Surfactants: their critical role in enhancing drug delivery to the lungs.

Morales JO, Peters JI, Williams RO 3rd.

Ther Deliv. 2011 May;2(5):623-41. Review.

PMID:
22833979
37.

Influence of particle size on regional lung deposition--what evidence is there?

Carvalho TC, Peters JI, Williams RO 3rd.

Int J Pharm. 2011 Mar 15;406(1-2):1-10. doi: 10.1016/j.ijpharm.2010.12.040. Epub 2011 Jan 11. Review.

PMID:
21232585
38.

Impact of obesity in asthma: evidence from a large prospective disease management study.

Peters JI, McKinney JM, Smith B, Wood P, Forkner E, Galbreath AD.

Ann Allergy Asthma Immunol. 2011 Jan;106(1):30-5. doi: 10.1016/j.anai.2010.10.015.

PMID:
21195942
39.

Preclinical evaluation of tacrolimus colloidal dispersion for inhalation.

Watts AB, Peters JI, Talbert RL, O'Donnell KP, Coalson JJ, Williams RO 3rd.

Eur J Pharm Biopharm. 2011 Feb;77(2):207-15. doi: 10.1016/j.ejpb.2010.11.013. Epub 2010 Dec 3.

PMID:
21130874
40.

Differences in physicians' self-reported knowledge of, attitudes toward, and responses to the black box warning on long-acting beta-agonists.

Karpel JP, Peters JI, Szema AM, Smith B, Anderson PJ.

Ann Allergy Asthma Immunol. 2009 Oct;103(4):304-10. doi: 10.1016/S1081-1206(10)60529-7.

PMID:
19852194
41.

Characterization and pharmacokinetic analysis of tacrolimus dispersion for nebulization in a lung transplanted rodent model.

Watts AB, Cline AM, Saad AR, Johnson SB, Peters JI, Williams RO 3rd.

Int J Pharm. 2010 Jan 15;384(1-2):46-52. doi: 10.1016/j.ijpharm.2009.09.040. Epub 2009 Sep 25.

PMID:
19782740
42.

Dose tolerability of chronically inhaled voriconazole solution in rodents.

Tolman JA, Nelson NA, Bosselmann S, Peters JI, Coalson JJ, Wiederhold NP, Williams RO 3rd.

Int J Pharm. 2009 Sep 8;379(1):25-31. doi: 10.1016/j.ijpharm.2009.06.003. Epub 2009 Jun 11.

PMID:
19524030
43.

Characterization and pharmacokinetic analysis of aerosolized aqueous voriconazole solution.

Tolman JA, Nelson NA, Son YJ, Bosselmann S, Wiederhold NP, Peters JI, McConville JT, Williams RO 3rd.

Eur J Pharm Biopharm. 2009 May;72(1):199-205. doi: 10.1016/j.ejpb.2008.12.014.

PMID:
19348016
44.

Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.

Tolman JA, Wiederhold NP, McConville JT, Najvar LK, Bocanegra R, Peters JI, Coalson JJ, Graybill JR, Patterson TF, Williams RO 3rd.

Antimicrob Agents Chemother. 2009 Jun;53(6):2613-5. doi: 10.1128/AAC.01657-08. Epub 2009 Mar 16.

45.
46.

Assessing the value of disease management: impact of 2 disease management strategies in an underserved asthma population.

Galbreath AD, Smith B, Wood PR, Inscore S, Forkner E, Vazquez M, Fallot A, Ellis R, Peters JI.

Ann Allergy Asthma Immunol. 2008 Dec;101(6):599-607. doi: 10.1016/S1081-1206(10)60222-0.

PMID:
19119703
47.

Recent developments in drug delivery to prolong allograft survival in lung transplant patients.

Watts AB, Williams RO 3rd, Peters JI.

Drug Dev Ind Pharm. 2009 Mar;35(3):259-71. doi: 10.1080/03639040802282904 . Review.

PMID:
18798087
48.

Inhaled nanoparticles--a current review.

Yang W, Peters JI, Williams RO 3rd.

Int J Pharm. 2008 May 22;356(1-2):239-47. doi: 10.1016/j.ijpharm.2008.02.011. Epub 2008 Feb 16. Review.

PMID:
18358652
49.

Cumulative recruitment experience in two large single-center randomized, controlled clinical trials.

Galbreath AD, Smith B, Wood P, Forkner E, Peters JI.

Contemp Clin Trials. 2008 May;29(3):335-42. Epub 2007 Oct 13.

PMID:
18032118
50.

Quantifying asthma symptoms in adults: the Lara Asthma Symptom Scale.

Wood PR, Smith B, O'Donnell L, Galbreath AD, Lara M, Forkner E, Peters JI.

J Allergy Clin Immunol. 2007 Dec;120(6):1368-72. Epub 2007 Nov 5.

PMID:
17981316

Supplemental Content

Loading ...
Support Center